These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15736066)

  • 61. The impact of clinicopathological studies on staging and survival in essential thrombocythemia, chronic idiopathic myelofibrosis, and polycythemia rubra vera.
    Kvasnicka HM; Thiele J
    Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):362-71. PubMed ID: 16810612
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [The morphology features of bone marrow in the prefibrotic-early primary myelofibrosis].
    Gong XB; Zhang XH; Lu XG; Tang QS; Gao X; Yang J
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jan; 33(1):25-30. PubMed ID: 22575188
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Histopathology of Ph1-negative chronic myeloproliferative diseases].
    Georgii A; Choritz H; Büsche G; Kreft A; Buhr T
    Pathologe; 1995 Jan; 16(1):62-9. PubMed ID: 7886016
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Megakaryocytopoiesis in myeloproliferative disorders].
    Podolak-Dawidziak M
    Acta Haematol Pol; 1992; 23(2 Suppl 1):19-22. PubMed ID: 1488868
    [No Abstract]   [Full Text] [Related]  

  • 65. Clinical, pathological and molecular features of the chronic myeloproliferative disorders: MPD 2005 and beyond.
    Michiels JJ
    Hematology; 2005; 10 Suppl 1():215-23. PubMed ID: 16188676
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bone marrow features of diagnostic impact in erythrocytosis.
    Thiele J; Kvasnicka HM; Diehl V
    Ann Hematol; 2005 Jun; 84(6):362-7. PubMed ID: 15803315
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Essential thrombocythemia vs. early/prefibrotic myelofibrosis: why does it matter.
    Barosi G
    Best Pract Res Clin Haematol; 2014 Jun; 27(2):129-40. PubMed ID: 25189724
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
    Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W
    Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hematopathologic findings in chronic idiopathic myelofibrosis.
    Thiele J; Kvasnicka HM
    Semin Oncol; 2005 Aug; 32(4):380-94. PubMed ID: 16202684
    [TBL] [Abstract][Full Text] [Related]  

  • 70. High concordance in grading reticulin fibrosis and cellularity in patients with myeloproliferative neoplasms.
    Pozdnyakova O; Wu K; Patki A; Rodig SJ; Thiele J; Hasserjian RP
    Mod Pathol; 2014 Nov; 27(11):1447-54. PubMed ID: 24762543
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prodromal myeloproliferative neoplasms: the 2008 WHO classification.
    Kvasnicka HM; Thiele J
    Am J Hematol; 2010 Jan; 85(1):62-9. PubMed ID: 19844986
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Bone marrow and peripheral blood findings in patients with extreme thrombocytosis. A report of 63 cases.
    Buss DH; O'Connor ML; Woodruff RD; Richards F; Brockschmidt JK
    Arch Pathol Lab Med; 1991 May; 115(5):475-80. PubMed ID: 2021316
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Working classification of chronic myeloproliferative disorders based on histological, haematological, and clinical findings.
    Burkhardt R; Bartl R; Jäger K; Frisch B; Kettner G; Mahl G; Sund M
    J Clin Pathol; 1986 Mar; 39(3):237-52. PubMed ID: 3457024
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Megakaryocyte precursors (pro- and megakaryoblasts) in bone marrow tissue from patients with reactive thrombocytosis, polycythemia vera and primary (essential) thrombocythemia. An immunomorphometric study.
    Thiele J; Wagner S; Degel C; Dienemann D; Wienhold S; Zankovich R; Fischer R; Stein H
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 58(4):295-302. PubMed ID: 1970693
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Primary (essential) thrombocythemia versus polycythemia vera rubra. A histomorphometric analysis of bone marrow features in trephine biopsies.
    Thiele J; Zankovich R; Schneider G; Kremer B; Fischer R; Diehl V
    Anal Quant Cytol Histol; 1988 Oct; 10(5):375-82. PubMed ID: 3207462
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Classification of chronic myeloproliferative diseases by bone marrow biopsies. Hematological and cytogenetic findings and clinical course.
    Georgii A; Vykoupil KF; Thiele J
    Bibl Haematol; 1984; (50):41-56. PubMed ID: 6590038
    [No Abstract]   [Full Text] [Related]  

  • 77. The value of bone marrow histology in differentiating between early stage Polycythemia vera and secondary (reactive) Polycythemias.
    Thiele J; Kvasnicka HM; Zankovich R; Diehl V
    Haematologica; 2001 Apr; 86(4):368-74. PubMed ID: 11325641
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Anagrelide-induced changes of megakaryopoiesis during therapy of chronic myeloproliferative disorders with thrombocythemia].
    Thiele J; Kvasnicka HM; Schmitt-Gräff A
    Pathologe; 2002 Nov; 23(6):426-32. PubMed ID: 12436295
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations.
    Boveri E; Passamonti F; Rumi E; Pietra D; Elena C; Arcaini L; Pascutto C; Castello A; Cazzola M; Magrini U; Lazzarino M
    Br J Haematol; 2008 Jan; 140(2):162-8. PubMed ID: 18028479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.